Maricel Apuli

Chief Accounting Officer · BridgeBio Pharma

Maricel Apuli (Chief Accounting Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $160K of BBIO (2,000 sh × $80.06, as filed), executed Jul 30. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$730K

shares × price, as filed

Last traded

Oct 30

Filed Nov 3

Median ADV $293.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $730K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

BBIO

BridgeBio Pharma, Inc. BBIO · 0 buys · 5 sells 5 filings

Recent filings

BBIOSALE BridgeBio Pharma, Inc. View filing → $146K
2,000 sh × $72.85
Exec Oct 30
Filed Nov 3 · 4:14 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $160K
2,000 sh × $80.06
Exec Jul 30
Filed Aug 3 · 4:20 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $143K
2,000 sh × $71.58
Exec Apr 30
Filed May 4 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $132K
2,000 sh × $66.00
Exec Feb 26
Filed Feb 27 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $149K
2,000 sh × $74.26
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET